Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Progyny (PGNY)
NASDAQ:PGNY
Holding PGNY?
Track your performance easily
PGNY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$19.60 - $42.08
Previous Close$24.82
Volume1.54M
Average Volume (3M)1.38M
Market Cap
$2.24B
Enterprise Value$2.00B
Total Cash (Recent Filing)$262.19M
Total Debt (Recent Filing)$17.06M
Price to Earnings (P/E)39.6
Beta1.27
Next Earnings
Oct 31, 2024EPS Estimate
$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.63
Shares Outstanding90,276,226
10 Day Avg. Volume1,490,103
30 Day Avg. Volume1,378,649
Standard Deviation0.16
R-Squared0.22
Alpha0.00058
Financial Highlights & Ratios
Price to Book (P/B)4.84
Price to Sales (P/S)1.98
Price to Cash Flow (P/CF)9.90
P/FCF Ratio10.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.76
Enterprise Value/Gross Profit8.36
Enterprise Value/Ebitda41.21
Forecast
1Y Price Target
$29.86Price Target Upside22.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Progyny News
Bulls Say, Bears Say
Bulls Say
Market ExpansionPGNY is now targeting additional groups from 250 to 1,000 members, including both ASO and fully-insured employers, and thereby adding 50M members to its TAM and taking its potential addressable lives to over 150M.
Revenue GrowthPGNY has a rapid growth profile, and analysts model a ~13% revenue CAGR over the next three years, with scale driving EBITDA margin expansion to high teens over that time.
Service ExpansionPGNY has already rolled out its menopause offering and started to roll out other maternity services, with the company noting that it expects ~1MM lives on these additional services for 2025.
Bears Say
EarningsAnnual guidance was lowered for the second time this year.
Financial PerformanceFollowing a third straight quarter of disappointing forward outlooks, and with a number of questions on how to get visibility into stabilizing the growth rate, analysts are downgrading PGNY from Outperform to Market Perform.
ManagementReduced confidence in management's visibility into care consumption and lack of definitive answers on volatility.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PGNY FAQ
What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $19.60 and its highest was $42.08 in the past 12 months.
What is Progyny’s market cap?
Currently, no data Available
When is Progyny’s upcoming earnings report date?
Progyny’s upcoming earnings report date is Oct 31, 2024 which is in 42 days.
How were Progyny’s earnings last quarter?
Progyny released its earnings results on Aug 06, 2024. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.169 by $0.001.
Is Progyny overvalued?
According to Wall Street analysts Progyny’s price is currently Undervalued.
Does Progyny pay dividends?
Progyny does not currently pay dividends.
What is Progyny’s EPS estimate?
Progyny’s EPS estimate is $0.14.
How many shares outstanding does Progyny have?
Progyny has 90,276,220 shares outstanding.
What happened to Progyny’s price movement after its last earnings report?
Progyny reported an EPS of $0.17 in its last earnings report, beating expectations of $0.169. Following the earnings report the stock price went down -18.998%.
Which hedge fund is a major shareholder of Progyny?
Among the largest hedge funds holding Progyny’s share is Farallon Capital Management, L.L.C.. It holds Progyny’s shares valued at 37M.
---
Progyny Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$29.86 (22.18% Upside)
$29.86 (22.18% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 844.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $41.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.8%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.44%
12-Months-Change
Fundamentals
Return on Equity
13.56%
Trailing 12-Months
Asset Growth
2.51%
Trailing 12-Months
Company Description
Progyny
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
---
PGNY Earnings Call
Q2 2024
0:00 / 0:00
---
PGNY Stock 12 Month Forecast
Average Price Target
$29.86
▲(22.18% Upside)
Technical Analysis
Best Analysts Covering PGNY
1 Year
1 Year Success Rate
3/15 ratings generated profit
1 Year Average Return
-15.74%
reiterated a buy rating last month
Copying Anne Samuel's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -15.74% per trade.
---